In conclusion, our study is the first to investigate the effects of RIPsC on allergic contact dermatitis, and we found that RIPsC alleviated local inflammation and prevented ear oedema by reducing neutrophil and CD8+ T lymphocyte infiltration and serum IL-17 levels. Here, IL17A is linked to allergic contact dermatitis.